Xyng
Natural health product licensed in Canada
- Licence holder
- Xyngular Corporation
- NPN or DIN-HM
- 80089054
- Status
- Active licence
- Licence date
- 6 November 2018
- Revision date
- 19 February 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Salix alba Source : Jeune écorce de branche Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 960 mg Potency : 15 % Salicin | 80 mg | Not calculated |
| Lepidium meyenii Source : Racine | 12 mg | Not calculated |
| Piper nigrum Source : Fruit Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 125 mg Potency : 95 % Piperine | 2.5 mg | Not calculated |
| Citrus aurantium Source : Immature fruit Extract : Matériel brut sec Extraction ratio : 13.5:1 Dry plant equivalent : 1,350 mg Potency : 10 % Synephrine | 100 mg | Not calculated |
| Rhodiola rosea Source : Racine Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 72 mg Potency : 2 % Salidroside | 12 mg | Not calculated |
| Rhodiola rosea Source : Racine Potency : 3 % Rosavins | Not specified | Not calculated |
| Capsicum annuum Source : Fruit | 20 mg | Not calculated |
| Panax ginseng Source : Racine | 12 mg | Not calculated |
Non-medicinal ingredients
Silice, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Caffeine helps to promote alertness and wakefulness, and to enhance cognitive performance. Caffeine helps to to relieve fatigue, to promote endurance, and to enhance motor performance. Caffeine helps to temporarily increase basal metabolic rate (thermogenesis). Provides antioxidants. Caffeine is used to help support cognitive function and reduce mental fatigue. Caffeine helps to (temporarily) increase energy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. If you experience irritability or insomnia, discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally). People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient. Some people may experience diarrhea, nausea, vomiting and abdominal pain.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. If symptoms persist or worsen, consult a health care practitioner. If you experience gastrointestinal symptoms such as nausea, vomiting, abdominal pain, dyspepsia, heartburn or diarrhea, discontinue use and consult a health care practitioner. If you have asthma or peptic ulcer disease, consult a health care practitioner prior to use. If you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates, consult a health care practitioner prior to use. If you are taking antidepressant medication, consult a health care practitioner prior to use. If you are taking hormone replacement therapy (HRT) or birth control pills, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking blood thinners or digoxin. Consult a health care practitioner prior to use if you have diabetes. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner. If you have an iron deficiency, consult a health care practitioner prior to use. Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If you have stomach ulcers or inflammation, consult a health care practitioner prior to use. If you are taking any other medications or natural health products, consult a health care practitioner prior to use, as black pepper/piperine may alter their effectiveness. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes. Consult a health care practitioner prior to use if you have cardiovascular disease, prostate disorders or are taking thyroid hormones.
- Contre-indications
If you are allergic to acetylsalicylic acid (ASA) or other salicylates, do not use this product. If you are pregnant or breastfeeding, do not use this product. If you have bipolar disorder or bipolar spectrum disorder, do not use this product. Do not use if you have scleroderma. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
Source
Official Health Canada record, licence 80089054
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging